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In the last two decades, numerous new biotechnological methods have greatly accelerated 
the efficiency of plant breeding, referred to as new plant-breeding techniques (NPBTs). 
These techniques are heterogeneous and may or may not involve modification of the plant 
genome2. In the former case, the end product may not possess the genetic modification, 
e.g. fruits and some vegetables. By the European definition, a genetically modified organ-
ism (GMO) is one “in which the genetic material has been altered in a way that does not 
occur naturally by mating and/or natural recombination” (The Council of the European 
Communities, 1990a, 1990b). These two directives, aimed at covering the legal issues 
of contained use and intentional release of GMOs, were passed not long after the first 
field trials with transgenic plants in the late 1980s. The intention was to protect human 
and animal health and the environment against possible risks from organisms created by 
recombinant-DNA technology. Both directives have been revised several times, resulting 
in 2001/18/EC and 2009/41/EC (European Parliament and European Council, 2001; 
2009). They list techniques that:
• give rise to genetic modification (annex I, part A of directive 2009/41/EC and 
annex IA part 1 of directive 2001/18/EC);
• are not considered to result in genetic modification (annex I, part B of directive 
2009/41/EC and annex IA, part 2 of directive 2001/18/EC); and
• yield organisms that are excluded from the directive (annex II, part A of directive 
2009/41/EC and annex IB of directive 2001/18/EC).
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However, the definition of what a GMO constitutes, or the use of which techniques will 
result in a GMO, still originate from 1990 and, consequently, do not match the develop-
ment of modern biotechnologies in plant breeding.
Since the vociferous discussions and subsequent formulation of GMO legislation in 
1990, numerous new techniques in plant breeding have been developed for which it is 
not clear if they have to be covered by GMO-legislation or not. Therefore, in 2007, the 
European Commission and the European National Competent Authorities (NCAs) initi-
ated a review of eight of these plant-breeding techniques defined as NPBTs. At the request 
of the NCAs, a working group—the new techniques working group (NTWG)—was 
established with the aim of clarifying the legal status of these new techniques in line 
with the GMO legislation. The final report of the NTWG was not officially published, 
but was distributed to the NCAs in 2012 and will be discussed below (New Techniques 
Working Group, 2012). In 2009, another working group was established on request 
of the directorate-general for the Environment of the European Commission with the 
mandate to summarize the state of science for adoption, economic impact and possibility 
of detection of these new techniques. The study, led by the Joint Research Center (JRC), 
was finished in 2011 and published as a comprehensive public JRC report and later in 
summarized form as a peer-reviewed article (Lusser et al., 2011, 2012).
Report of the NTWG to the European Commission
The preamble of the final report includes the statement that the views expressed are 
those of an expert working group and do not necessarily represent those of the European 
Commission or the Member States Competent Authorities (New Techniques Working 
Group, 2012). The NTWG, consisting of two experts per European Member State, at 
first compiled a list of eight techniques that had to be discussed. This list included: oligo-
directed mutagenesis (ODM); zinc finger nuclease (ZFN) technology; cisgenesis; grafting; 
agro-infiltration; RNA-dependent DNA methylation (RdDM); reverse breeding; and 
synthetic genomics (SG). Next, the NTWG defined and interpreted terms important 
for their analyses and then examined the techniques one by one in relation to directives 
2001/18/EC and 2009/41/EC.
ODM
Concerning ODM (Beetham et al., 1999) the NTWG came to the conclusion that the 
oligonucleotides cannot be considered as recombinant nucleic acids. The reasoning for 
this majority opinion was as follows. Oligonucleotides introduced into the cell by ODM 
are not capable of replication and are not heritable. Furthermore, the resulting organ-
ism itself is captured by annex IB because the technique entails mutagenesis. This view 
is shared by several competent authorities in Europe [e.g. the German Central Biosafety 
Commission (ZKBS, 2012)]. However, a minority of NTWG experts suggested that 
ODM leads to a new combination of genetic material resulting in a heritable change in 
the DNA sequence and that the oligonucleotide has been prepared outside the organism. 
Both are criteria listed in annex IA, part 1 of directive 2001/18/EC.
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ZFN
The ZFN technique (Bibikowa et al., 2001) was divided into subcategories named ZFN-1, 
-2 and -3. In the case of ZFN-1, the nuclease is applied without integration of the respec-
tive gene and no additional template DNA is added. ZFN-2 resembles ZFN-1 but, in 
addition, an added template DNA for guided DNA-repair, which is not integrated into 
the genome of the host, is explored. Considering the non-replicative template DNA and 
a not-integrated ZFN construct, the experts agreed by majority that ZFN-1 and -2 are 
captured by annex IB (directive 2001/18/EC) or annex IIA (directive 2009/41/EC). In 
the view of the experts, ZFN-1 and -2 result in a GMO that should be excluded from 
GMO regulation because the provoked genetic change is a mutation that can also be 
introduced by other forms of mutagenesis and cannot be distinguished from a mutation 
introduced by other techniques. ZFN-3 is characterized by the addition of a larger stretch 
of homologous DNA as a repair template for homologous recombination, aiming for 
a site-specific integration of transgenes (gene targeting). ZFN-3 was considered by all 
experts of the NTWG to fall within the scope of directive 2001/18/EC and to be covered 
by annex IA, part 1 as the resulting plants would be transgenic. However, some cases may 
meet the criterion of self-cloning and might be considered to fall outside of the scope of 
annex IIB of directive 2009/41/EC. The opinions expressed by the experts of the NTWG 
concerning ZFN-1 to -3 are shared by the German ZKBS and, concerning ZFN-3, also 
by the European Food Safety Authority (EFSA).
Cisgenesis
In the case of cisgenesis/intragenesis, recombinant DNA is introduced into the genome 
of the recipient plant (Belfanti et al., 2004). The difference from transgenesis is that the 
recombinant DNA originates from a crossable plant (i.e. the same or a closely related 
species). All experts came to the conclusion that this technique falls under the scope of 
directive 2001/18/EC and is sufficiently covered by annex IA, part 1. This conclusion 
is shared by the ZKBS and EFSA. In addition, experts of the different working groups 
expressed the opinion that, in some cases, cisgenesis may be equivalent to self-cloning 
(EFSA, 2012a; New Techniques Working Group, 2012).
Grafting
Applying a non-GM scion to a GM rootstock (MacKenzie et al., 1991) results in a chimeric 
plant that falls within the scope of directive 2001/18/EC, whereas the fruits, seeds or 
 progeny should not be regulated as GMOs. For the converse (i.e. non-GM rootstock 
and GM scion), the chimera, as well as the fruits, seeds or progeny from the scion, are 
transgenic and, therefore, fall under the scope of directive 2001/18/EC (New Techniques 
Working Group, 2012). This view is agreed with by other expert bodies (e.g. ZKBS).
Agro-Infiltration
Agro-infiltration (Lee et al., 2001) was divided into two subcategories by the NTWG 
experts. In the case of agro-infiltration sensu stricto, only non-germline tissue is infiltrated 
and the T-DNA of the Agrobacterium accumulates but does not replicate in the cells. The 
aim of this method is not to produce offspring in which the T-DNA is integrated into 
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the genome, which would result in a transgenic plant. As recombinant Agrobacterium 
is a genetically modified microorganism, the infiltrated plants containing recombinant 
Agrobacterium would fall within the scope of directive 2009/41/EC. In rare cases, the T-
DNA might integrate into the genome, but as there is no selection on these integration 
events, a transfer of the recombinant DNA to the progeny, albeit highly unlikely, has 
to be controlled. The majority of the experts concluded that progenies of these plants, 
in which it is proven that no recombinant DNA is integrated into the genome, should 
be considered to fall outside the scope of directive 2001/18/EC. The second category is 
agro-infiltration of germline tissues, called “floral dip.” This method is usually employed 
to generate offspring that do contain recombinant DNA in the genome. Therefore, all 
experts agreed that offspring that do harbor a stable integration event fall within annex IA, 
part 1 of directive 2001/18/EC. The German ZKBS agreed with this view, but expressed 
the opinion that multicellular organisms (including plants) that do contain some cells 
with a recombinant genome should not be defined as GMO. This point was not explicitly 
discussed by the NTWG experts.
RdDM
Regarding RdDM (Mette et al., 2000), all experts agreed that, in cases where any DNA 
that encodes the effector RNA is integrated into the genome, the resulting plants are 
GMOs. In cases where the DNA is only transiently present and not stably integrated, the 
intermediate plant is a GMO but not the fruit, seeds or other progeny. In cases in which 
the RNA is directly delivered into the cell without being able to replicate, the experts agreed 
that such a plant should not be defined as GMO. Summarizing the different scenarios that 
are possible using RdDM, the conclusion of the NTWG was that all plants containing 
RNA-dependent DNA methylations only are not genetically modified. Therefore, such 
plants would not fall under the scope of directive 2001/18/EC (New Techniques Working 
Group, 2012). This view is shared by the German ZKBS.
Reverse Breeding
During reverse breeding (Dirks et al., 2009), a number of steps are taken that transiently 
might involve genetic modification. In line with conclusions drawn for other NPBTs such 
intermediate plants would fall under the scope of directive 2001/18/EC, but not their 
fruits, seeds or other progeny if they do not contain recombinant DNA. As the goal of 
RB is to produce parental genomes of superior F1-hybrids in a controlled manner, the 
screening procedure is on genomes containing no genetic modification at all. Therefore, the 
NTWG experts agreed that plants resulting from RB do not fall under the scope of direc-
tive 2001/18/EC. This view is in agreement with the opinion of the German ZKBS.
Synthetic Genomics
Synthetic genomics (Smith et al., 2003) is a rapidly evolving field within synthetic biology, 
which may include techniques of genetic modification. Because of the breadth of SG, 
the NTWG did not discuss it in general, but only some aspects of it (New Techniques 
Working Group, 2012). The view of the experts is that, in most cases, SG would fall 
under the scope of directive 2001/18/EC and/or 2009/41/EC if a living (micro-)organ-
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ism is the recipient of the synthetic genome. As most of the work done so far has been 
basic research in microorganisms, this falls under the scope of directive 2009/41/EC. The 
NTWG offers two possible interpretations of how this technique might be covered in 
future, either with emphasis on the recipient, which is not considered as a (micro-)organ-
ism, or with emphasis on the resulting entity which is considered to be a (micro-)organism 
(New Techniques Working Group, 2012). In the first case, the technique falls outside 
of GMO legislation, in the latter case it falls under the scope of the respective directive 
2001/18/EC or 2009/41/EC. 
Report of the Joint Research Center Working Group
The JRC working group—established in 2009 on request of the Directorate-General 
for the Environment—analyzed various aspects of the NPBTs which were the state of 
science for adoption, the economic impact and the possibility of detection of these new 
techniques. The main conclusions have been published and are as follows:
• a significant part of R&D on NPBTs was done in public research institutes in 
Europe, but most of the patents are held by US-based companies;
• some of the NPBTs are already in the late stages of commercial breeding pro-
grams and will appear on the market in the near future; and
• many regulatory jurisdictions around the world will make decisions on the legisla-
tion of NPBTs (Lusser et al., 2011; 2012).
The last point has implications for the adoption of these techniques; regulation of them 
as GMOs will hamper the adoption of new crops. Furthermore, differences in the regu-
lation of new crops in different parts of the world will cause severe asynchrony in the 
approval of such crops. Consequently, Lusser et al. (2012) have demanded that global 
discussion concerning governance of the NPBTs is necessary to achieve synchronized and 
evidence-based governance.
Opinion of the EFSA Concerning the Safety Assessment of 
Cisgenesis and ZFN-3
The EFSA expressed its scientific opinion in 2012 upon request by the European Com-
mission to address the question of whether the existing guidelines to assess the safety of 
GMOs can be applied also to NPBTs. To perform an analysis of selected NPBTs and 
their potential risks, the EFSA established two working groups consisting of GMO panel 
members and external experts. At first, cisgenesis and intragenesis were evaluated and the 
results published in 2012 (EFSA, 2012a). The working group came to the conclusion that 
the existing guidance documents for GMO-risk assessment are applicable to NPBTs and 
do not need to be developed further (EFSA, 2012a). Furthermore, the experts expressed 
the opinion that, in some cases of cisgenic plants, fewer event-specific data may be needed 
to perform the risk assessment.
In the case of ZFN-3, the EFSA working group at first changed the term ZFN to 
SDN (site-directed nuclease) as in recent years in total four different nuclease systems 
have been developed that are applicable for the introduction of sequence-specific DNA-
Schiemann and Hartung
0	 New	DNA-Editing	Approaches:	Methods,	Applications	and	Policy	for	Agriculture
strand breaks and the specific incorporation or exchange of genetic material. The expert 
group came to the conclusion that the aim of the SDN-3 technique is to integrate or 
exchange recombinant DNA and, therefore, it is comparable to transgenesis but more 
precise (EFSA, 2012b). Therefore, the existing guidance documents for transgenic plants 
are applicable also for plants derived from SDN-3 but, again, in some cases (e.g. SDN-3 
combined with cisgenesis) fewer event-specific data might be needed for the risk assess-
ment (EFSA, 2012b).
Report of the European Academies Science Advisory Council
The EASAC has provided an extensive report on the risks and benefits of so-called “crop 
genetic improvement technologies,” a term that includes NPBTs, gene technology and 
techniques that will evolve in the future (European Academies Science Advisory Council, 
2013). The report did not find evidence of intrinsic higher risk of GM technology in 
comparison to conventional breeding. This finding is based on solid science conducted in 
several thousand research projects and published in the last 20 years. Therefore, EASAC 
came to the following key conclusion and recommendation (European Academies Sci-
ence Advisory Council, 2013):
The trait and product not the technology in agriculture should be regulated, and 
the regulatory framework should be evidence-based.
This request for a trait/product-based regulation reflects the scientific evidence that is 
very solidly based on GMO-safety research and risk analyses accumulated in the last two 
decades (Heap, 2012; Swiss National Science Foundation, 2012; Hartung and Schiemann, 
2014). The EASAC report was recently endorsed by Anne Glover, chief scientific adviser 
to the president of the European Commission. Besides the EASAC statement mentioned 
above that intrinsic risks of gene technologies do not exist, concerning NPBTs, she stated 
that “… we shouldn´t make the mistake of regulating them to death as we have done 
with GM” (Glover, 2013).
Additional European Activities to Discuss 
the Legal Status of NPBTs
In Europe, NPBTs continue to be discussed vociferously. In 2012, in Alnarp, Sweden, 
Mistra-Biotech organized an international workshop,—Future of Plant Biotechnology in 
Europe—involving various stakeholders, to discuss the governance of NPBTs (Lehrman 
and Alexandersson, 2012). Experts from EPSO, EFSA, the Swedish Gene Technology 
Advisory Board, and other competent authorities as well as the Federation of Swedish 
Farmers and journalists discussed the implications of the currently unclear regulatory 
status of NPBTs. 
In June, 2014, several meetings dealing with the legal uncertainty of NPBTs took 
place. A symposium in Quedlinburg, Germany, was dedicated to explaining these tech-
niques to stakeholders from the national government, national NGOs and to farmers 
and representatives of the national press. The urgent need to clarify the legal status of 
NPBTs in Europe and the negative effects of the current legal uncertainty were expressed 
(Julius-Kühn-Symposium, 2014).
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A similar workshop was organized in London by the Biotechnology and Biological Sci-
ence Research Council (BBSRC). Members of the European Commission, NCAs, farmers 
and scientists from all over Europe discussed the opportunities of NPBTs, their uncertain 
legal status and, especially, what may be done to ameliorate this unsatisfactory situation. 
As a result of the workshop, a position statement of the BBSRC—to be disseminated and 
discussed in the UK and Europe—will be published later in 2014 (BBSRC, 2014).
The Position of the European Technology Platform “Plants for 
the Future”
The ETP published a statement on NPBTs—“Plants for the Future”—in which it wel-
comed the conclusions described above that the legal definition of a GMO does not apply 
to most of the NPBTs (European Technology Platform, 2012). To provide the plant and 
agricultural sectors with legal certainty concerning NPBTs, the ETP requested a move 
of the existing GMO legislation towards a more suitable science-based and transparent 
regulation system (European Technology Platform, 2012):
It is thus crucial for companies to be certain now that their investments will not 
be in vain and that their future products will not be subject to the uncertain 
outcome of politicized regulatory procedures, as is the case with GMOs.
To provide European Member State representatives with an overview on the technical and 
legal interpretations of the private and public plant-breeding sectors as regards possible 
regulatory requirements for the individual techniques as well to show the socio-economic 
importance of these techniques for industry and society at large, the ETP “Plants for the 
Future” and New Breeding Technologies (NBTs) platforms jointly hosted an informational 
meeting on NPBTs, “The Future of Plant Breeding Techniques in the European Union,” 
in June, 2014, attended by representatives from Member State national governments, the 
European Commission, industry, academia, and the farming community. A key message 
was that the European Commission’s delays in clarifying the legal status of the NPBTs 
weakens the competitiveness of, and hinders job creation in, the EU agro-food sector. It 
is important that the European Commission creates favorable regulatory conditions for 
European plant breeders to maintain leadership in research and innovation. European 
policymakers are facing difficulties in modifying the existing legislation, due to the absence 
of consensus amongst the main political EU actors, and the strong divergence in views 
amongst Member States and stakeholders. This situation mainly reflects broad hostility 
to GMOs amongst EU citizens.
Summarizing the discussions described above, one can conclude that there is general 
agreement amongst experts to define a GMO on the presence of foreign recombinant 
DNA. When an organism does not contain recombinant DNA, it should not be risk 
 assessed and regulated as a GMO. This view also includes techniques that involve 
 creation of GMOs as intermediate steps, but in which the end product does not contain 
recombinant DNA (e.g. ZFN-1, -2, agro-infiltration sensu stricto, and reverse breeding). 
Furthermore, this would include other, so far not extensively discussed, techniques like 
fast breeding, in which an intermediate plant contains a transgene to accelerate the breed-
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ing process, but which is subsequently crossed out and only the null-segregants are used 
for further breeding. Such an approach concerning GMO legislation would support the 
further development and adoption of NPBTs in Europe, but it can only be the first step 
towards a more flexible evidence-based and transparent regulatory system for crop genetic 
improvement technologies. The future regulatory framework to allow international har-
monization and to avoid trade disruptions between countries and continents should take 
the new trait/product into account and not the technology to generate it.
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